According to Quest Diagnostics 's latest financial reports and stock price the company's current Operating Margin is 12.49%. At the end of 2021 the company had an Operating Margin of 24.09%.
Year | Operating Margin | Change |
---|---|---|
2021 | 24.09% | 20.68% |
2020 | 19.96% | 43.35% |
2019 | 13.93% | 13.27% |
2018 | 12.30% | -7.97% |
2017 | 13.36% | -7.54% |
2016 | 14.45% | -1.83% |
2015 | 14.72% | 28.91% |
2014 | 11.42% | -39.47% |
2013 | 18.86% | 30.35% |
2012 | 14.47% | 26.94% |
2011 | 11.40% | -29.07% |
2010 | 16.07% | -2.42% |
2009 | 16.47% | 17.18% |
2008 | 14.06% | 3.29% |
2007 | 13.61% | -17.44% |
2006 | 16.48% | -0.36% |
2005 | 16.54% | 1.55% |
2004 | 16.29% | 4.61% |
2003 | 15.57% | 17.95% |
2002 | 13.20% | 44.01% |
2001 | 9.17% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() LabCorp LH | 19.39% | 55.24% | ๐บ๐ธ USA |
![]() Translate Bio
TBIO.defunct | 18.52% | 48.26% | ๐บ๐ธ USA |
![]() Psychemedics PMD | -10.53% | -184.31% | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | -3.11% | -124.90% | ๐บ๐ธ USA |
![]() Qiagen QGEN | 27.79% | 122.50% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | -26.89% | -315.29% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.